129 related articles for article (PubMed ID: 25271379)
1. Characteristics of hip fracture patients with and without muscle atrophy/weakness: predictors of negative economic outcomes.
Cui Z; Schoenfeld MJ; Bush EN; Chen Y; Burge R
J Med Econ; 2015 Jan; 18(1):1-11. PubMed ID: 25271379
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic characteristics of hip fracture patients with and without muscle atrophy/weakness in the United States.
Zhao Y; Chen SY; Lee YC; Wu N
Arch Osteoporos; 2013; 8():127. PubMed ID: 23532737
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic characteristics of total hip replacement patients with high health care costs and high health care use.
Cui Z; Schoenfeld M; Chen Y; Bush EN; Burge R
Am J Phys Med Rehabil; 2015 Apr; 94(4):269-79. PubMed ID: 25785921
[TBL] [Abstract][Full Text] [Related]
4. Retrospective database study to assess the economic impact of hip fracture in the United Kingdom.
Lambrelli D; Burge R; Raluy-Callado M; Chen SY; Wu N; Schoenfeld MJ
J Med Econ; 2014 Nov; 17(11):817-25. PubMed ID: 25164473
[TBL] [Abstract][Full Text] [Related]
5. Association between teriparatide adherence and healthcare utilization and costs among hip fracture patients in the United States.
Zhao Y; Johnston SS; Smith DM; McMorrow D; Krege J; Krohn K
Bone; 2014 Mar; 60():221-6. PubMed ID: 24361596
[TBL] [Abstract][Full Text] [Related]
6. [A 10-year-review (1998 - 2007) on 3449 cases of osteoporotic hip fractures: trend of hospitalization and inpatient costs].
Cheng ZA; Lin DK; Liu DB; Shen HY; Chen Q; Qiu QW; Liu SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Nov; 29(11):1128-31. PubMed ID: 19173940
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the Charlson Comorbidity Index and cost of treating hip fractures: implications for bundled payment.
Johnson DJ; Greenberg SE; Sathiyakumar V; Thakore R; Ehrenfeld JM; Obremskey WT; Sethi MK
J Orthop Traumatol; 2015 Sep; 16(3):209-13. PubMed ID: 25697846
[TBL] [Abstract][Full Text] [Related]
9. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
Burton TM; Lacey M; Liu F; Yu Y; Monsalvo ML; Lang K; Sander S
J Med Econ; 2012; 15(6):1217-25. PubMed ID: 22857539
[TBL] [Abstract][Full Text] [Related]
10. Impact of comorbidities on hospitalization costs following hip fracture.
Nikkel LE; Fox EJ; Black KP; Davis C; Andersen L; Hollenbeak CS
J Bone Joint Surg Am; 2012 Jan; 94(1):9-17. PubMed ID: 22218377
[TBL] [Abstract][Full Text] [Related]
11. Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom.
Gutiérrez L; Roskell N; Castellsague J; Beard S; Rycroft C; Abeysinghe S; Shannon P; Robbins S; Gitlin M
J Med Econ; 2011; 14(1):99-107. PubMed ID: 21222505
[TBL] [Abstract][Full Text] [Related]
12. Economic implications of hip fracture: health service use, institutional care and cost in Canada.
Wiktorowicz ME; Goeree R; Papaioannou A; Adachi JD; Papadimitropoulos E
Osteoporos Int; 2001; 12(4):271-8. PubMed ID: 11420776
[TBL] [Abstract][Full Text] [Related]
13. Impact of structural and economic factors on hospitalization costs, inpatient mortality, and treatment type of traumatic hip fractures in Switzerland.
Mehra T; Moos RM; Seifert B; Bopp M; Senn O; Simmen HP; Neuhaus V; Ciritsis B
Arch Osteoporos; 2017 Dec; 12(1):7. PubMed ID: 28013447
[TBL] [Abstract][Full Text] [Related]
14. [Study on direct economic-burden and its risk factors of osteoporotic hip fracture].
Luo LZ; Xu L
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):669-72. PubMed ID: 16471214
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics, treatment patterns, and economic burden in patients treated for neuroendocrine tumors in the United States: a retrospective cohort study.
Chuang CC; Bhurke S; Chen SY; Brulais S; Gabriel S
J Med Econ; 2015 Feb; 18(2):126-36. PubMed ID: 25325180
[TBL] [Abstract][Full Text] [Related]
16. Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan.
Mori T; Tamiya N; Jin X; Jeon B; Yoshie S; Iijima K; Ishizaki T
Arch Osteoporos; 2018 Mar; 13(1):37. PubMed ID: 29603078
[TBL] [Abstract][Full Text] [Related]
17. Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics.
Bera R; Offord S; Zubek D; Lau G; Lin J; Baker RA; Karson C
J Med Econ; 2013; 16(4):522-8. PubMed ID: 23360177
[TBL] [Abstract][Full Text] [Related]
18. Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness.
Wu N; Chen SY; Lee YC; Zhao Y
Clinicoecon Outcomes Res; 2013; 5():271-80. PubMed ID: 23836997
[TBL] [Abstract][Full Text] [Related]
19. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
20. Healthcare utilization and costs in children with stable and uncontrolled epilepsy.
Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
